The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes

2021 ◽  
Author(s):  
R. Ross MacLean ◽  
Suzanne Spinola ◽  
Gabriella Garcia-Vassallo ◽  
Mehmet Sofuoglu
Keyword(s):  
Chronic Pain ◽  
Treatment Outcomes ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Disorder Treatment ◽  
The Impact

Dual diagnosis inpatient treatment outcomes for individuals with co-occurring chronic pain and opioid use disorder

2018 ◽  
Vol 19 (3) ◽  
pp. S32
Author(s):  
C. Cutter ◽  
F. Buono ◽  
S. Ackerman ◽  
M. Brennan ◽  
D. Mueller ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Treatment Outcomes ◽  
Dual Diagnosis ◽  
Inpatient Treatment ◽  
Opioid Use Disorder ◽  
Opioid Use

scholarly journals COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics

2021 ◽  
Author(s):  
Lauren Caton ◽  
Hannah Cheng ◽  
Hélène Chokron Garneau ◽  
Tammy Fisher ◽  
Briana Harris-Mills ◽  
...  
Keyword(s):  
Primary Care ◽  
Behavioral Health ◽  
Medication Management ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Primary Care Clinics ◽  
Urine Drug ◽  
Disorder Treatment ◽  
Primary Care Practices ◽  
The Impact

Abstract Background With the onset of the COVID-19 crisis, many federal agencies relaxed policies regulating opioid use disorder treatment. The impact of these changes has been minimally documented. The abrupt nature of these shifts provides a naturalistic opportunity to examine adaptations for opioid use disorder treatment in primary care. Objective To examine change in medical and behavioral health appointment frequency, visit type, and management of patients with opioid use disorder in response to COVID-19. Design A 14-item survey queried primary care practices that were enrolled in a medications for opioid use disorder statewide expansion project. Survey content focused on changes in service delivery because of COVID-19. The survey was open for 18 days. Participants We surveyed 338 clinicians from 57 primary care clinics located in California, including federally qualified health centers and look-alikes. A representative from all 57 clinics (100%) and 118 staff (34.8% of all staff clinicians) participated in the survey. Main Measures The survey consisted of seven dimensions of practice: medical visits, behavioral health visits, medication management, urine drug screenings, workflow, perceived patient demand, and staff experience. Key Results A total of 52 of 57 (91.2%) primary care clinics reported practice adaptations in response to COVID-19 regulatory changes. Many clinics indicated that both medical (40.4%) and behavioral health visits (53.8%) were now exclusively virtual. Two-thirds (65.4%) of clinics reported increased duration of buprenorphine prescriptions and reduced urine drug screenings (67.3%). The majority (56.1%) of clinics experienced an increase in patient demand for behavioral health services. Over half (56.2%) of clinics described having an easier or unchanged experience retaining patients in care. Conclusions Many adaptations in the primary care approach to patients with opioid use disorder may be temporary reactions to COVID-19. Further evaluation of the impact of these adaptations on patient outcomes is needed to determine whether changes should be maintained post-COVID-19.

The influence of anxiety sensitivity on opioid use disorder treatment outcomes.

2019 ◽  
Vol 27 (1) ◽  
pp. 64-77 ◽  
Author(s):  
Catherine Baxley ◽  
Jeremiah Weinstock ◽  
Patrick J. Lustman ◽  
Annie A. Garner
Keyword(s):  
Treatment Outcomes ◽  
Anxiety Sensitivity ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Disorder Treatment

scholarly journals Initiating Buprenorphine/Naloxone for Opioid Use Disorder in the Emergency Department

2020 ◽  
Vol 43 (1) ◽  
pp. 12-22
Author(s):  
Keysha Low
Keyword(s):  
Emergency Departments ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Opioid Agonist ◽  
Health Crisis ◽  
Multifaceted Approach ◽  
Public Health Crisis ◽  
Recommended Treatment ◽  
Disorder Treatment ◽  
The Impact

The opioid crisis continues to affect individuals across the country, and requires a multifaceted approach to minimize the impact of this public health crisis. Through the chronic consumption of opioids, many individuals can become dependent on opioids and develop opioid use disorder. Buprenorphine/naloxone is the recommended treatment for patients living with opioid use disorder. The Emergency Strategic Clinical Network™ within Alberta Health Services is targeting the crisis through emergency departments by implementing a provincially standardized program. The Buprenorphine/Naloxone Initiation in Emergency Departments program includes screening for opioid use disorder, treatment initiation with the medication buprenorphine/naloxone, and providing rapid and reliable referrals to community clinics for titration and continuing patient care. This paper provides an overview of opioids, opioid use disorder, opioid agonist treatments such as buprenorphine/naloxone, and specifically details the program and protocol available in Alberta.

Tweeting Stigma: An Exploration of Twitter Discourse Regarding Medications Used for Both Opioid Use Disorder and Chronic Pain

2021 ◽  
pp. 002204262098650
Author(s):  
Patricia Dekeseredy ◽  
Cara L. Sedney ◽  
Bayan Razzaq ◽  
Treah Haggerty ◽  
Henry H. Brownstein
Keyword(s):  
Chronic Pain ◽  
Treatment Options ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Conspiracy Theories ◽  
On Demand ◽  
Social Media Site ◽  
The Social ◽  
Lack Of Control ◽  
The Impact

We examined the content of tweets on the social media site Twitter to better understand the contemporary discourse about medications for opioid use disorder (MOUD), how this chat contributes to the pervasive underpinnings of drug addiction, chronic pain stigma, and the impact it has on demand and availability of treatment. A retrospective review of tweets over 3 months containing keywords buprenorphine, naltrexone, methadone, or bupe was conducted resulting in 5,068 tweets. A content analysis was carried out focusing on a subset of tweets. Themes emerged from including suspicion and conspiracy theories about MOUD, and frustration and lack of control over their treatment options. Other tweets shared stigmatizing language and attitudes related to OUD/MOUD (e.g., “Junkies”). Twitter is a rich source of data reflecting thoughts, opinions, and sentiments entities regarding MOUD. However, this information can contain malicious comments that perpetuate stigma for people with OUD and result in avoidance of treatment.

Sign in / Sign up

Export Citation Format

Share Document